Entera Share Price

Entera Share Price

NASDAQ: ENTX | Micro Cap | Healthcare
$3.25
+$0.25 (8.15%) Last updated on 19 Nov, 2026 | 01:27 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Entera Stock Performance

Open
$3.16
Prev. Close
$3.00
Circuit Range
N/A
Day Range
$3.15 - $3.26
Year Range
$0.93 - $4.20
Volume
11,936
Average Traded
$3.21

Entera Share Price Today

As of 19 November 2026, Entera Bio Ltd.'s share price is $3.25. The stock opened at $3.16, compared to its previous close of $3.00. During today's trading session, Entera Bio Ltd.'s share price traded between $3.15 and $3.26, with an average price of $3.21. Over the past 52 weeks, the stock has recorded a high of $4.20 and a low of $0.93. In terms of performance, Entera Bio Ltd.'s share price has risen by 140.74% over the last six months and is up 31.05% on a year-on-year basis.

Entera Share Price Chart

Line chart of the Entera price trend over the selected period. The price rose overall, ranging from 3.14 to 3.26, ending at 3.25.
$3.15$3.26
L
Show Current Price
H

Entera Stock Fundamentals & Key Indicators

Market Cap
$150.12M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.17
Revenue (TTM)
$40.00M
Return On Equity (TTM)
-10.73%
Profit Margin
-28600.00%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-416.56%

Entera Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$3.02-$3.51-$7.31-$15.60
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-16.23%-108.26%-113.41%

Entera Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.13$0.00$0.18$0.04
Net Profit-$13.07-$8.89-$9.54-$11.44
Net Profit Margin-10053.85%N/A-5300.00%-28600.00%
Income ChangeN/A31.98%-7.31%-19.92%

Entera Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.70.420.510.28
Current Assets15.38.9711.2612.85
Total Assets15.999.3911.7713.13
Non Current Liabilities0.690.130.290.03
Current Liabilities2.21.181.091.34
Total Liabilities2.891.311.381.37
Shareholders' Equity13.18.0810.3911.75

Entera Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-7.37-6.82-7.31-12.5
Investing-0.110.0-0.02-0.1
Financing13.714.486.040.01

About Entera

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

Entera Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$3.20
$3.23
+0.62%
Oct 2026
$2.95
$3.21
+9.18%
Sep 2026
$2.91
$2.94
-3.76%
Aug 2026
$2.94
$3.06
+2.52%
Jul 2026
$1.90
$2.98
+68.36%
Jun 2026
$1.37
$1.77
+31.11%
May 2026
$1.21
$1.35
+15.38%
Apr 2026
$1.16
$1.17
+5.41%
Mar 2026
$1.39
$1.11
-20.43%
Feb 2026
$1.38
$1.40
+1.82%
Jan 2026
$1.92
$1.37
-27.51%
Dec 2025
$2.30
$1.89
-23.79%

Entera Share Price FAQs